Form 4: Organon & Co. Executive Joseph T. Morrissey, Jr. Receives Stock Options and Restricted Stock Units

Joseph T. Morrissey, Jr., Head of Manufacturing at Organon & Co., reports the acquisition of stock options and restricted stock units.

Summary

• On March 29, 2024, Joseph T. Morrissey, Jr., Head of Manufacturing at Organon & Co., was granted 119,825 stock options and 29,255 restricted stock units (RSUs).
• The stock options have an exercise price of $18.80 and vest in three equal installments on March 29, 2025, March 29, 2026, and March 29, 2027.
• The RSUs represent a contingent right to receive one share of Organon common stock for each RSU and also vest in three equal installments on March 29, 2025, March 29, 2026, and March 29, 2027.
• Following these transactions, Morrissey directly owns 119,825 stock options and 29,255 RSUs.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive as it reflects standard executive compensation practices, aligning management with shareholder interests. The vesting schedule promotes long-term commitment.

Positives

• The grant of stock options and RSUs aligns the executive's interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the executive.

Industry Context

Stock options and restricted stock units are common forms of executive compensation used to incentivize performance and align management's interests with those of shareholders.

Comparison to Industry Standards

• Executive compensation packages, including stock options and RSUs, are standard practice among publicly traded companies like Organon & Co.
• Comparable pharmaceutical companies such as Pfizer (PFE) and Merck (MRK) also utilize similar equity-based compensation strategies to attract and retain key personnel.
• The specific number of options and RSUs granted would typically be benchmarked against industry peers based on company size, performance, and executive role.

Stakeholder Impact

• Shareholders may view the equity grants positively as they incentivize management to improve company performance.
• Employees may see this as a positive sign of investment in leadership.

Key Dates